The Manufacturers Life Insurance Company Has $1.24 Million Holdings in Cloudera Inc (NYSE:CLDR)

Large institutional investors continue to accumulate shares of Cloudera, Inc. according to recent SEC filings.   Typically, institutional investors subject a potential investment through stringent fundamental analysis and technical analysis before investing into a new firm.  Many large institutional investors have taken notice of Cloudera, Inc. due to their expertise in machine learning, data analytics, and analyzing big data.  Intel and BlackRock Inc. are large holders of Cloudera; probably causing many institutional investors to take a deeper look into this trailblazer in data analytics and machine learning.

 part-1-introducing-the-cloudera-data-science-workbench-2-638

Intel Editorial: One Simple Truth about Artificial Intelligence in Healthcare: It’s Already Here

“Intel and partners throughout the healthcare industry – including GE Healthcare, Siemens, Sharp Healthcare, the Broad Institute, UCSF and the Mayo Clinic – are successfully applying AI solutions today, from the back office to the doctor’s office, from the emergency room to the living room.” ~ see hyperlink below

http://markets.businessinsider.com/news/stocks/intel-editorial-one-simple-truth-about-artificial-intelligence-in-healthcare-it-s-already-here-1019011624 

Intel using their arm, Intel Capital has invested heavy into new startups who have unique technologies in artificial intelligence, data analytics, machine learning, and handing big data.   One of the company who have helped Intel successfully is Cloudera, Inc. who specializes into analyzing big data using machine learning and data analytics techniques.

In fact, Intel is the largest shareholder of Cloudera, Inc. and maintains a partnership with Cloudrea, Inc. for their engineers to develop firmware to be embedded into their semiconductors for new innovative applications in artificial intelligence, data analytics, and machine learning.  The semiconductor industry is a commodity driven industry where large companies like Apple Computer has leveraged to use other suppliers semiconductors and/or chip in their products.   Intel moved into working with Cloudera, Inc. to create products with added value for artificial intelligence, data analytics, machine learning where other competitors do not have protected moats where their clients can not use leverage to control pricing.   Cloudera, Inc. has a unique portfolio  of patents to protect their moat.  Their patents also serve as a barrier to entry into these new frontiers.

https://www.nasdaq.com/symbol/cldr/institutional-holdings

Cloudera, Inc. is worthy of further due diligence in how the firm is helping Intel gain a competitive advantage in artificial intelligence within the health care field.